Opexa Therapeutics Inc (OPXA) - Financial Analysis Review

Summary

Opexa Therapeutics Inc (Opexa), formerly PharmaFrontiers Corp. is a biopharmaceutical company that focuses on the development of personalized immunotherapies for autoimmune disorders, rheumatoid arthritis, diabetes and heart failure. The companys portfolio of products comprise Tcelna, a T-cell immunotherapy used for the treatment of secondary progressive multiple sclerosis; OPX-212, for neuromyelitis optica. The company uses T-cell technology platform for the development of patient-specific T-cell therapies. It operates in the US and Canada. Opexa is headquartered in the Woodlands, Texas, the US

GlobalData's Opexa Therapeutics Inc (OPXA) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Opexa Therapeutics Inc Key Recent Developments:

Nov 14,2016: Opexa Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Aug 11,2016: Opexa Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update
May 12,2016: Opexa Therapeutics Reports First Quarter 2016 Financial Results and Provides Corporate Update
Mar 15,2016: Opexa Therapeutics Reports 2015 Year End Financial Results and Provides Corporate Update
Nov 10,2015: Opexa Therapeutics Reports Third Quarter 2015 Financial Results and Provides Corporate Update


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial positio